QIAGEN NV
(NYSE : QGEN)

( )
QGEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.15%427.741.0%$611.97m
ABTAbbott Laboratories 2.24%106.780.8%$555.30m
ISRGIntuitive Surgical, Inc. 0.99%700.002.4%$507.50m
MDTMedtronic Plc 2.74%106.440.6%$471.19m
DHRDanaher Corp. 0.82%211.400.7%$463.23m
BDXBecton, Dickinson & Co. -0.16%224.641.0%$390.99m
DXCMDexCom, Inc. 0.00%400.197.9%$332.41m
INOInovio Pharmaceuticals, Inc. -5.19%11.515.9%$323.82m
SYKStryker Corp. 0.20%207.091.3%$287.02m
BSXBoston Scientific Corp. 0.00%38.001.0%$286.72m
QDELQuidel Corp. -0.12%198.407.7%$262.73m
VARVarian Medical Systems, Inc. -0.01%171.939.1%$253.67m
BAXBaxter International, Inc. 0.05%79.581.8%$242.31m
ALGNAlign Technology, Inc. 0.00%322.866.4%$232.00m
EWEdwards Lifesciences Corp. 0.14%77.820.4%$224.51m

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.